Latest Blogs, Articles, and More View More >>
View More >>
The PD-1 inhibitor was approved along with a companion diagnostic, the PD-L1 IHC 22C3 pharmDx test, and is indicated for patients who progressed on or after platinum-containing chemotherapy or EGFR- or ALK-targeted agents in patients harboring those mutations.
Every October, pink ribbons appear to signal the start of Breast Cancer Awareness Month. Pink has become the color of breast cancer, but some survivors don't like the color pink and they have a good reason for feeling the way they do.
From the time my wife was diagnosed, people asked if she smoked. If the answer was yes, would that make it OK that she was sick?
It’s all about having a plan. Plans give hope. Plans inspire.
The combination was approved for patients with BRAF V600 wild-type unresectable or metastatic melanoma, based on results from a phase 2 study.
When diagnosing prostate cancer, doctors consider staging and grading. In grading, a score is assigned based on the Gleason grading system.
Understanding state-of-the-art care helps patients with prostate cancer to choose treatments